| Literature DB >> 31432802 |
F Reeßing1, M C A Stuart2, D F Samplonius3, R A J O Dierckx4, B L Feringa1, W Helfrich3, W Szymanski1.
Abstract
Medical magnetic resonance imaging (MRI) produces high-resolution anatomical images of the human body, but has limited capacity to provide useful molecular information. The light-responsive, liposomal MRI contrast agent described herein could be used to provide an intrinsic theranostic aspect to MRI and enable tracking the distribution and cargo release of drug delivery systems upon light-triggered activation.Entities:
Mesh：
Substances：
Year: 2019 PMID： 31432802 DOI： 10.1039/c9cc05516a
Source DB: PubMed Journal: Chem Commun (Camb) ISSN： 1359-7345 Impact factor: 6.222